# Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies

> **NCT05448222** · — · UNKNOWN · sponsor: **First Affiliated Hospital of Wenzhou Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Sarcopenia

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic Test: gait speed; ct scan; grip strength and chair stand test

## Key facts

- **NCT ID:** NCT05448222
- **Lead sponsor:** First Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05448222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05448222, "Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05448222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*